MedPath

Physical Exercise as a Targeted Therapy in Patients With Chronic Rheumatic Muscle Inflammation

Not Applicable
Conditions
Myositis
Interventions
Other: Physical Exercise
Registration Number
NCT01184625
Lead Sponsor
Karolinska Institutet
Brief Summary

The objectives of this study are to test if hypoxia in muscle tissue is an important factor contributing to clinical symptoms in chronic rheumatic muscle inflammation and to evaluate if a 12 week endurance exercise program will improve muscle tissue hypoxia and disability in patients with chronic rheumatic muscle inflammation.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
30
Inclusion Criteria
  • Patients with chronic, stable polymyositis or dermatomyositis with diagnosis of definite or probable polymyositis or dermatomyositis (Bohan and Peter 1975)
  • Age 18-80 years
  • Duration since diagnosis > 6 months
  • Exercising < once a week,
  • Stable disease activity and medication for at least one month.

Ten healthy controls matched for age, gender and physical exercise level will be included.

Exclusion Criteria
  • Severe pulmonary fibrosis
  • Heart or lung conditions that contraindicate vigorous exercise
  • Severe osteoporosis
  • Not being able to perform the exercise program.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
ExercisePhysical Exercise-
Primary Outcome Measures
NameTimeMethod
Hypoxia related metabolites.After 12 weeks of endurance exercise intervention/ non intervention.
Secondary Outcome Measures
NameTimeMethod
Muscle impairment.After 12 weeks of endurance exercise intervention/ non intervention.

Trial Locations

Locations (1)

Rheumatology unit, Karolinska University Hospital

🇸🇪

Stockholm, Sweden

© Copyright 2025. All Rights Reserved by MedPath